The mouse lymphoma assay in the wake of ICH4 - Where are we now?

Mutagenesis

Volumn 14, Issue 3, 1999, Pages 265-270

  Cole, Jane ^a   Harrington Brock, Karen ^b   Moore, Martha M ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; CANCER DIAGNOSIS; CLINICAL PROTOCOL; DIAGNOSTIC TEST; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0032951041     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/14.3.265     Document Type: Review

References (45)

1. Applegate, M., Moore, M., Broder, C., Burrell, A., Juhn, G., Kasweck, K., Lin, P-F., Wadhams, A. and Hozier, J. (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl Acad. Sci. USA, 87, 51-55.
2. Blazak, W.F., Stewart, B.E., Galperin, I., Allen, K.L., Rudd, C.J., Mitchell, A.D. and Caspary, W.J. (1986) Chromosome analysis of trifiuorothymidine-resistant L5178Y mouse lymphoma cell colonies. Environ. Mutagen., 8, 229-240.
3. Brusick, D. (1986) Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations. Environ. Mutagen., 8, 879-886.
4. Clark, J.L, Hart, D., Vojta, P., Harrington-Brock, K., Barrett, J., Moore, M. and Tindall, K. (1998) Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk+\-3.7.2C mouse lymphoma cells. Mutagenesis, 13, 427-439.
5. Clive, D., Flamm, W. and Machesko, M. (1972a) Mutagenicity of hycanthone in mammalian cells. Mutat. Res., 14, 262.
6. Clive, D., Flamm, W. and Patterson, J. (1972b) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res., 16, 77.
7. Clive, D., Johnson, K.O., Spector, J.F.S., Batson, A.G. and Brown, M.M. (1979) Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system. Mutat. Res., 59, 61-108.
8. Clive, D., Caspary, W., Kirby, P.E., Krehl, R., Moore, M., Mayo, J. and Oberly, T.J. (1987) Guide for performing the mouse lymphoma assay for mammalian cell mutagenicity. Mutat. Res., 189, 143-156.
9. Clive, D., Glover, P., Applegate, M. and Hozier, J. (1990) Molecular aspects of chemical mutagenesis in L5178Y/tk+/- mouse lymphoma cells. Mutagenesis, 5, 191-197.
10. Clive, D., Glover, P., Krehl, R. and Poorman-Allen, P. (1991) Mutagenicity of 2-amino-N6-hydroxyadenine (AHA) at three loci in L5178Y/tk+/- mouse lymphoma cells: molecular and preliminary cytogenetic characterizations of AHA-induced tk-/-mutants. Mutat. Res., 253, 73-82.
11. Clive, D., Bolcsfoldi, G., Clements, J., Cole, J., Honma, M., Majeska, J., Moore, M., Muller, L., Myhr, B., Oberly, T., Oudelhkim, M.-C., Rudd, C., Shimada, H., Sofuni, J., Thybaud, V. and Wilcox, P. (1995) Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ. Mol. Mutagen., 25, 165-168.
12. Cole, J., Arlett, C.F., Lowe, J. and Bridges, B.A. (1982) The mutagenic potency of 1,8-dinitropyrene in cultured mouse lymphoma cells. Mutat. Res., 93, 213-220.
13. Cole, J., Arlett, C.F., Green, M.H., Lowe, J. and Muriel, W. (1983) A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cells. Mutat. Res., 111, 371-386.
14. Cole, J., Muriel, W.J. and Bridges, B.A. (1986) The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/-(3.7.2c)] mouse lymphoma cells. Mutagenesis, 1, 157-167.
15. Cole, J., Diot, M.C, Richmond, F.N. and Bridges, B.A. (1990) Comparative induction of gene mutations and chromosome damage by 1-methoxy-1,3,5-cycloheptatriene (MCHT), 2. Results using L5178Y mouse lymphoma cells to detect both gene and chromosome damage; validation with ionizing radiation, methyl methanesulphonate, ethyl methanesulphonate and benzo[a]pyrene. Mutat. Res., 230, 81-91.
16. Cole J., Richmond, F.N. and Bridges, B.A. (1991) The mutagenicity of 2-amino-N6-hydroxyadenine to L5178Y tk +/-3.7.2C mouse lymphoma cells: measurement of mutations to ouabain, 6-thioguanine and trifluorothymidine resistance and the induction of micronuclei. Mutat. Res., 253, 55-62.
17. Dearfield, K., Auletta, A., Cimino, M. and Moore, M. (1991) Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity. Mutat. Res., 258, 259-283.
18. Department of Health and Human Services (1997) Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Food and Drug Administration, Rockville, MD.
19. Doerr, C.L., Harrington-Brock, K. and Moore, M.M. (1989) Micronucleus, chromosome aberration and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells. Mutat. Res., 222, 191-203.
20. Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K., Ushio, N., Nishi, Y., Nakadate, M., Clements, J. and Sofuni, T. (1999) Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis, 14, 5-22.
21. -/- mouse-lymphoma mutagenesis assay system. Mutat. Res., 84, 169-181.
22. Hozier, J., Sawyer, J., Clive, D. and Moore, M. (1982) Cytogenetic distinction between the TK+ and TK-chromosome in the L5178Y TK +V-3.7.2C mouse-lymphoma cell line. Mutat. Res., 105, 451-456.
23. Hozier, J.C., Sawyer, J.R. and Moore, M.M. (1989) High-resolution Cytogenetic analysis of L5178Y TK+/-3.7.2C cells: variation in chromosome 11 breakpoints among small-colony TK-/-mutants. Mutat. Res., 214, 195-199.
24. Liechty, M.C., Rauchfuss, H.S., Lugo, M.H. and Hozier, J.C. (1993) Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/-mouse-lymphoma cells and spontaneous tk-/-mutants. Mutat. Res., 286, 299-307.
25. Liechty, M.C, Hassanpour, Z., Hozier, J.C. and Clive, D. (1994) Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis, 9, 423-427.
26. Liechty, M.C., Crosby, H., Jr, Murthy, A., Davis, L.M., Caspary, W.J. and Hozier, J.C. (1996) Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lymphoma cells. Mutat. Res., 371, 265-271.
27. Matsuoka, A., Yamakage, K., Kusakabe, H., Wakuri, S., Asakura, M., Noguchi, T., Sugiyama, T., Shimada, H., Nakayama, S., Kasahara, Y., Takahashi, Y., Miura, K.F., Hatanaka, M., Ishidate, M.Jr, Monta, T., Watanabe, K., Hara, M., Odawara, K., Tanaka, N., Hayashi, M. and Sofuni, T. (1996) Re-evaluation of chromosomal aberration induction on nine mouse lymphoma assay 'unique positive' NTP carcinogens. Mutat. Res., 369, 243-252.
28. Meyer, M., Brock, K., Lawrence, K., Casto, B. and Moore, M.M. (1986) Evaluation of the effect of agar on the results obtained in the L5178Y mouse lymphoma assay. Environ. Mutagen., 8, 727-740.
29. Mitchell, A.D., Auletta, A.E., Clive, D., Kirby, P.E., Moore, M.M. and Myhr, B.C. (1997) The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay a phase III report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 394, 177-303.
30. - mouse lymphoma cells at varying times posttreatment. Environ. Mutagen., 4, 499-519.
31. Moore, M.M. and Doerr, C.L. (1990) Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/ TK(+/-)-3.7,2C mouse lymphoma cells. Mutagenesis, 5, 609-614.
32. Moore, M.M. and Howard, B.E. (1982) Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cell in RPMI-1640 medium. Mutat. Res., 104, 287-294.
33. Moore, M.M., Clive, D., Howard, B.E., Batson, A.G. and Turner, N.T. (1985a) In situ analysis of trifluorothymidine-resistant (TFT) mutants of L5178Y/ TK+/-mouse lymphoma cells. Mutat. Res., 151, 147-159.
34. Moore, M.M., Clive, D., Hozier, J.C, Howard, B.E., Batson, A.G., Turner, N.T. and Sawyer, J. (1985b) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells. Mutat. Res., 151, 161-174.
35. Moore, M.M., Harrington-Brock, K., Doerr, C. and Dearfiled, K. (1989) Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci. Mutagenesis, 4, 394-403.
36. Moore, M.M., Harington-Biock, K., Parker, L., Doerr, C.L. and Hozier, J.C. (1991) Genotoxicity of 2-amino-6-N-hydroxyadenine (AHA) to mouse lymphoma and CHO cells. Mutat. Res., 253, 63-71.
37. Moore, M.M., Collard, D. and Harrington-Brock, K. (1999a) Failure to adequately use positive control data leads to poor quality mouse lymphoma data assessments. Mutagenesis, 14, 261-263.
38. Moore, M.M., Harrington-Brock, K. and Cole, J. (1999b) Issues for conducting the microtitre version of the mouse lymphoma thymidine kinase (tk) assay and a critical review of data generated in a collaborative trial using the microtiter method. Mutagenesis, 14, 271-281.
39. Moore-Brown, M. (1981) The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (Tk-\-) mutants from L5178Y/Tk+\-mouse lymphoma cells. Mutat. Res., 85, 363-378.
40. Oberly, T.J., Yount, D.L. and Garriott, M.L. (1997) A comparison of the soft agar and microtitre methodologies for the L5178Y tk+/-mouse lymphoma assay. Mutat. Res., 388, 59-66.
41. Sofuni, T., Honma, M., Hayashi, M., Shimada, H., Tanaka, N., Wakuri, S., Awogi, T., Yamamoto, K.I., Nishi, Y. and Nakadate, M. (1996) Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the microwell method: interim report of an international collaborative study. Mutagenesis, 11, 349-55.
42. Sofuni, T., Wilcox, P., Shimada, H., Clements, J., Honma, M., Clive, D., Green, M., Thybaud, V., San, R.H., Elliott, B.M. and Muller, L. (1997) Mouse lymphoma workshop: Victoria, British Columbia, Canada, March 27, 1996. Protocol issues regarding the use of the microwell method of the mouse lymphoma assay. Environ. Mol. Mutagen., 29, 434-438.
43. Tennant, R., Margolin, G., Shelby, M., Zeiger, E., Haseman, J., Spalding, J., Caspary, W., Rsnick, M., Stasiewicz, S., Anderson, B. and Minor, R. (1987) Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science, 236, 933-941.
44. -/- mouse lymphoma assay. In Kilbey, B., Legator, M. and Ramel, C. (eds), Handbook of Mutagenicity Test Procedures. Elsevier, Amsterdam, The Netherlands, pp. 239-268.
45. Zhang, L.S., Honma, M., Matsuoka, A., Suzuki, T., Sofuni, T. and Hayashi, M. (1996) Chromosome painting analysis of spontaneous and methyl methanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies. Mutat. Res., 370, 181-190.